<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Thrombocytosis | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Thrombocytosis  Definition: An abnormally elevated platelet count in the peripheral blood, generally defined as a platelet count greater than 450 x 10^9/L (450,000/µL) Clinical...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Thrombocytosis | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Thrombocytosis  Definition: An abnormally elevated platelet count in the peripheral blood, generally defined as a platelet count greater than 450 x 10^9/L (450,000/µL) Clinical...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Thrombocytosis | Hematology">
<meta name="twitter:description" content="Overview of Thrombocytosis  Definition: An abnormally elevated platelet count in the peripheral blood, generally defined as a platelet count greater than 450 x 10^9/L (450,000/µL) Clinical...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="active" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="thrombocytosis" class="section level1 unnumbered">
<h1>Thrombocytosis<a class="anchor" aria-label="anchor" href="#thrombocytosis"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-thrombocytosis" class="section level2 unnumbered">
<h2>
<strong>Overview of Thrombocytosis</strong><a class="anchor" aria-label="anchor" href="#overview-of-thrombocytosis"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> An abnormally elevated platelet count in the peripheral blood, generally defined as a platelet count greater than 450 x 10^9/L (450,000/µL)</li>
<li>
<strong>Clinical Significance:</strong> Thrombocytosis can increase the risk of thrombosis (blood clots) and, paradoxically, in some cases, bleeding</li>
<li>
<strong>Classification:</strong>
<ul>
<li>Reactive (Secondary) Thrombocytosis: The most common type, caused by an underlying condition</li>
<li>Essential (Primary) Thrombocythemia: A myeloproliferative neoplasm characterized by sustained thrombocytosis and increased risk of thrombosis and bleeding</li>
</ul>
</li>
</ul>
</div>
<div id="reactive-thrombocytosis-secondary-thrombocytosis" class="section level2 unnumbered">
<h2>
<strong>Reactive Thrombocytosis (Secondary Thrombocytosis)</strong><a class="anchor" aria-label="anchor" href="#reactive-thrombocytosis-secondary-thrombocytosis"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> An elevated platelet count that occurs as a <em>reaction</em> to an underlying condition. It’s not a primary disorder of the bone marrow</li>
<li>
<strong>Characteristics:</strong>
<ul>
<li>Transient: Platelet count usually returns to normal once the underlying condition resolves</li>
<li>Mild to Moderate Elevation: Platelet counts are typically less than 1000 x 10^9/L, but this is not a strict cutoff</li>
<li>Lack of Clonal Marker: Absence of genetic mutations (e.g., JAK2, CALR, MPL) associated with essential thrombocythemia</li>
</ul>
</li>
<li>
<strong>Common Causes of Reactive Thrombocytosis:</strong>
<ul>
<li>Infections:
<ul>
<li>Acute and chronic bacterial infections</li>
<li>Fungal infections</li>
<li>Viral infections (less common)</li>
</ul>
</li>
<li>Inflammation:
<ul>
<li>Autoimmune disorders (e.g., rheumatoid arthritis, inflammatory bowel disease)</li>
<li>Vasculitis</li>
<li>Acute pancreatitis</li>
<li>Tissue injury (e.g., trauma, surgery, burns)</li>
</ul>
</li>
<li>Iron Deficiency Anemia (IDA):
<ul>
<li>Platelet count may normalize after iron repletion</li>
</ul>
</li>
<li>Hemorrhage:
<ul>
<li>Following acute blood loss, the platelet count may temporarily increase</li>
</ul>
</li>
<li>Splenectomy:
<ul>
<li>Removal of the spleen leads to increased platelet counts, as the spleen normally removes senescent platelets</li>
<li>Platelet counts can be very high (&gt;1000 x 10^9/L) after splenectomy</li>
</ul>
</li>
<li>Rebound Thrombocytosis:
<ul>
<li>Following recovery from thrombocytopenia caused by chemotherapy or bone marrow suppression</li>
</ul>
</li>
<li>Malignancy:
<ul>
<li>Certain cancers (e.g., lung, breast, ovarian) can cause reactive thrombocytosis</li>
</ul>
</li>
<li>Medications:
<ul>
<li>Corticosteroids</li>
<li>Epinephrine</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Pathophysiology:</strong>
<ul>
<li>Increased Thrombopoietin (TPO) Production:
<ul>
<li>Many of the underlying conditions associated with reactive thrombocytosis stimulate the production of thrombopoietin (TPO), the primary regulator of platelet production</li>
<li>TPO is produced mainly by the liver and kidneys</li>
<li>TPO stimulates megakaryocyte proliferation and differentiation in the bone marrow, leading to increased platelet production</li>
</ul>
</li>
<li>Increased Release of Platelets from the Bone Marrow:
<ul>
<li>Inflammatory cytokines can promote the release of platelets from the bone marrow storage pool</li>
</ul>
</li>
<li>Decreased Platelet Sequestration:
<ul>
<li>Splenectomy removes the spleen, the main site of platelet destruction and sequestration, leading to increased platelet counts</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Clinical Features of Reactive Thrombocytosis:</strong>
<ul>
<li>Often asymptomatic</li>
<li>Symptoms of the underlying condition may be present (e.g., fever, pain, inflammation)</li>
<li>Thrombotic or bleeding complications are <em>rare</em> in reactive thrombocytosis, especially when platelet counts are &lt;1000 x 10^9/L</li>
</ul>
</li>
<li>
<strong>Laboratory Findings in Reactive Thrombocytosis:</strong>
<ul>
<li>Complete Blood Count (CBC):
<ul>
<li>Elevated platelet count (usually &lt; 1000 x 10^9/L)</li>
<li>May see other abnormalities depending on the underlying cause (e.g., elevated WBC count in infection, anemia in iron deficiency)</li>
</ul>
</li>
<li>Peripheral Blood Smear:
<ul>
<li>Increased number of platelets</li>
<li>Platelets usually appear normal in size and morphology</li>
<li>May see other abnormalities related to the underlying condition (e.g., microcytes in iron deficiency)</li>
</ul>
</li>
<li>Iron Studies:
<ul>
<li>May be abnormal in iron deficiency anemia (low serum iron and ferritin, high TIBC)</li>
</ul>
</li>
<li>Inflammatory Markers:
<ul>
<li>Elevated ESR, CRP, and/or other inflammatory markers</li>
</ul>
</li>
<li>JAK2, CALR, and MPL Mutation Testing:
<ul>
<li>
<em>Negative</em>: Helps to rule out essential thrombocythemia (ET)</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="essential-thrombocythemia-primary-thrombocythemia" class="section level2 unnumbered">
<h2>
<strong>Essential Thrombocythemia (Primary Thrombocythemia)</strong><a class="anchor" aria-label="anchor" href="#essential-thrombocythemia-primary-thrombocythemia"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A myeloproliferative neoplasm characterized by sustained thrombocytosis and increased risk of thrombosis and bleeding. It’s a primary disorder of the bone marrow</li>
<li>
<strong>Diagnostic Criteria (WHO Criteria):</strong>
<ul>
<li>Sustained Platelet Count ≥450 x 10^9/L</li>
<li>Bone Marrow Showing Increased Numbers of Megakaryocytes with Abnormal Morphology
<ul>
<li>Increased numbers of large, mature megakaryocytes with hyperlobated nuclei</li>
</ul>
</li>
<li>Exclusion of Other MPNs: Absence of criteria for PV, PMF, or CML</li>
<li>Presence of a Clonal Marker or Evidence of Clonal Hematopoiesis:
<ul>
<li>
<em>JAK2</em> V617F mutation (present in approximately 50-60% of patients)</li>
<li>
<em>CALR</em> mutation (present in approximately 25% of patients)</li>
<li>
<em>MPL</em> mutation (present in approximately 5% of patients)</li>
<li>If all three mutations are negative, other evidence of clonality is required</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Pathophysiology:</strong>
<ul>
<li>Mutations in <em>JAK2, CALR, or MPL</em> Genes:
<ul>
<li>These mutations lead to constitutive activation of signaling pathways that control megakaryocyte proliferation and platelet production</li>
<li>
<em>JAK2</em> V617F: A point mutation in the <em>JAK2</em> gene</li>
<li>
<em>CALR</em> mutations: Insertions or deletions in the <em>CALR</em> gene</li>
<li>
<em>MPL</em> mutations: Mutations in the <em>MPL</em> gene (thrombopoietin receptor)</li>
</ul>
</li>
<li>Megakaryocyte Hyperplasia: Increased numbers of megakaryocytes in the bone marrow</li>
<li>Increased Platelet Production: Megakaryocytes produce excessive numbers of platelets</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Many patients are asymptomatic at diagnosis</li>
<li>Thrombotic Events:
<ul>
<li>Stroke</li>
<li>Transient ischemic attack (TIA)</li>
<li>Myocardial infarction (heart attack)</li>
<li>Deep vein thrombosis (DVT)</li>
<li>Pulmonary embolism (PE)</li>
<li>Erythromelalgia (burning pain and redness in the extremities)</li>
</ul>
</li>
<li>Bleeding Events:
<ul>
<li>Paradoxically, some patients may experience bleeding due to abnormal platelet function</li>
<li>Easy bruising</li>
<li>Nosebleeds</li>
<li>Gastrointestinal bleeding</li>
</ul>
</li>
<li>Splenomegaly: Enlarged spleen (less common than in PV or PMF)</li>
<li>Constitutional Symptoms: Fatigue, night sweats, weight loss (less common)</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC:
<ul>
<li>Elevated platelet count (sustained &gt;450 x 10^9/L)</li>
<li>WBC count: May be normal or slightly elevated</li>
<li>RBC count: Usually normal, but may be slightly elevated</li>
</ul>
</li>
<li>Peripheral Blood Smear:
<ul>
<li>Thrombocytosis (increased platelets)</li>
<li>Large platelets (megathrombocytes)</li>
<li>Abnormal platelet morphology (e.g., hypogranular platelets)</li>
</ul>
</li>
<li>Bone Marrow Examination:
<ul>
<li>Increased numbers of megakaryocytes with abnormal morphology (e.g., large, hyperlobated nuclei)</li>
<li>May see increased granulopoiesis</li>
<li>Little or no reticulin fibrosis (unlike primary myelofibrosis)</li>
</ul>
</li>
<li>Molecular Testing:
<ul>
<li>Positive for <em>JAK2</em>, <em>CALR</em>, or <em>MPL</em> mutation (in most cases)</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Low-Risk Patients (Low Risk of Thrombosis):
<ul>
<li>Low-Dose Aspirin: To reduce the risk of thrombosis</li>
</ul>
</li>
<li>High-Risk Patients (High Risk of Thrombosis):
<ul>
<li>Low-Dose Aspirin</li>
<li>Cytoreductive Therapy:
<ul>
<li>Hydroxyurea: To lower the platelet count</li>
<li>Anagrelide: Inhibits platelet production</li>
<li>Interferon-alpha: May be used in younger patients or pregnant women</li>
</ul>
</li>
</ul>
</li>
<li>Risk Stratification:
<ul>
<li>Various risk scoring systems are used to estimate the risk of thrombosis and guide treatment decisions</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="distinguishing-reactive-thrombocytosis-from-essential-thrombocythemia" class="section level2 unnumbered">
<h2>
<strong>Distinguishing Reactive Thrombocytosis from Essential Thrombocythemia</strong><a class="anchor" aria-label="anchor" href="#distinguishing-reactive-thrombocytosis-from-essential-thrombocythemia"><i class="fas fa-link"></i></a>
</h2>
<div class="inline-table"><table class="table table-sm">
<colgroup>
<col width="19%">
<col width="39%">
<col width="41%">
</colgroup>
<thead><tr class="header">
<th>Feature</th>
<th>Reactive Thrombocytosis</th>
<th>Essential Thrombocythemia</th>
</tr></thead>
<tbody>
<tr class="odd">
<td>Platelet Count</td>
<td>Usually &lt; 1000 x 10^9/L</td>
<td>≥450 x 10^9/L</td>
</tr>
<tr class="even">
<td>Platelet Morphology</td>
<td>Usually normal</td>
<td>Large platelets, abnormal morphology</td>
</tr>
<tr class="odd">
<td>Cause</td>
<td>Underlying condition (e.g., infection, inflammation, IDA)</td>
<td>Clonal myeloproliferative neoplasm</td>
</tr>
<tr class="even">
<td>
<em>JAK2</em>, <em>CALR</em>, <em>MPL</em>
</td>
<td>Negative</td>
<td>Often positive</td>
</tr>
<tr class="odd">
<td>Thrombosis Risk</td>
<td>Low</td>
<td>Increased</td>
</tr>
<tr class="even">
<td>Splenomegaly</td>
<td>Absent or mild</td>
<td>Can be present (but less prominent than PMF)</td>
</tr>
</tbody>
</table></div>
</div>
<div id="general-laboratory-tests-for-thrombocytosis" class="section level2 unnumbered">
<h2>
<strong>General Laboratory Tests for Thrombocytosis</strong><a class="anchor" aria-label="anchor" href="#general-laboratory-tests-for-thrombocytosis"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Complete Blood Count (CBC) with Peripheral Blood Smear:</strong> Essential for diagnosis and classification</li>
<li>
<strong>Iron Studies:</strong> To rule out iron deficiency anemia</li>
<li>
<strong>Inflammatory Markers:</strong> (ESR, CRP) to assess for underlying inflammation</li>
<li>
<strong>Mutation Testing:</strong> (JAK2, CALR, and MPL) to rule out essential thrombocythemia and primary myelofibrosis</li>
<li>
<strong>Bone Marrow Aspiration and Biopsy:</strong> May be necessary to evaluate for MPNs or other bone marrow disorders</li>
</ul>
</div>
<div id="key-terms-42" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-42"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Thrombocytosis:</strong> Elevated platelet count</li>
<li>
<strong>Reactive Thrombocytosis:</strong> Thrombocytosis due to an underlying condition</li>
<li>
<strong>Essential Thrombocythemia (ET):</strong> Clonal MPN with sustained thrombocytosis</li>
<li>
<strong>Myeloproliferative Neoplasm (MPN):</strong> Clonal disorder of hematopoietic stem cells</li>
<li>
<strong>JAK2, CALR, MPL:</strong> Genes commonly mutated in MPNs</li>
<li>
<strong>Phlebotomy:</strong> Removal of blood to reduce red cell mass</li>
<li>
<strong>Hydroxyurea:</strong> A chemotherapeutic drug used to suppress bone marrow proliferation</li>
<li>
<strong>Anagrelide:</strong> A drug that inhibits platelet production</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="pseudo.html">Pseudo</a></div>
<div class="next"><a href="qualitative.html">Qualitative</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#thrombocytosis">Thrombocytosis</a></li>
<li><a class="nav-link" href="#overview-of-thrombocytosis">Overview of Thrombocytosis</a></li>
<li><a class="nav-link" href="#reactive-thrombocytosis-secondary-thrombocytosis">Reactive Thrombocytosis (Secondary Thrombocytosis)</a></li>
<li><a class="nav-link" href="#essential-thrombocythemia-primary-thrombocythemia">Essential Thrombocythemia (Primary Thrombocythemia)</a></li>
<li><a class="nav-link" href="#distinguishing-reactive-thrombocytosis-from-essential-thrombocythemia">Distinguishing Reactive Thrombocytosis from Essential Thrombocythemia</a></li>
<li><a class="nav-link" href="#general-laboratory-tests-for-thrombocytosis">General Laboratory Tests for Thrombocytosis</a></li>
<li><a class="nav-link" href="#key-terms-42">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/blob/main/book/03-09-platelet-quantitative-thrombocytosis.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/blob/edit/main/book/03-09-platelet-quantitative-thrombocytosis.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-28 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
